Funded Research

2018

Yukon

Improving Prostate Cancer Diagnosis and Management in the Yukon

John Lewis

2018

Ottawa

Analysis of the innate lymphocyte landscape in prostate cancer.

Dr. Michele Ardolino

2018

Grand River

Exploring the impact of a smoking cessation program on Prostate Cancer Patients undergoing Radiation Therapy Treatment

Dr. Ernest Osei

2018

Grand River

PEARL: PSMA PET/CT, Evaluating its Application in Real Life

Dr. Joda Kuk

2018

Manitoba

Lamin A/C levels in circulating tumor cells

Dr. Sabine Mai

2018

Manitoba

Identification of clinically relevant lysosomotropic agents to treat aggressive prostate cancer.

Dr. Spencer Gibson

2018

Avalon

Engrailed 2 as biomarker and driver of prostate cancer metastasis.

Dr.Jules JE Doré, Ph.D.

2018

Avalon

Characterization of a novel Myc-Pygo2 ribonucleoprotein complex that drives prostate cancer cell proliferation

Dr. Kenneth Kao

2018

Swift Current

Factors affecting Prostate Cancer outcomes in SK: a comprehensive epidemiological review

Dr. Michael Szafron